{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:55:18Z","timestamp":1793055318193,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.clml.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T11:03:09Z","timestamp":1557745389000},"page":"e425-e429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Incidence of Silent Thrombosis in Patients Younger Than 60 Years With Myeloproliferative Neoplasms: Single-Center Egyptian Study"],"prefix":"10.1016","volume":"19","author":[{"given":"Mervat M.","family":"Mattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Nassef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"El Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Roshdy","family":"El Masry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdelkader","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Abdul","family":"Gawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.05.005_bib1","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/leu.2008.253","article-title":"Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation","volume":"22","author":"Landolfi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.05.005_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/1076029615578166","article-title":"Prevalence of JAK2V617F mutation in deep venous thrombosis patients and its clinical significance as a thrombophilic risk factor: Indian perspective","volume":"21","author":"Singh","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.clml.2019.05.005_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.05.005_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","volume":"5","author":"De Stefano","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.clml.2019.05.005_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11899-017-0400-3","article-title":"Risk factors for and management of MPN-associated bleeding and thrombosis","volume":"12","author":"Martin","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.clml.2019.05.005_bib6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00277-016-2765-0","article-title":"Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience","volume":"95","author":"Mattar","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.05.005_bib7","first-page":"40","article-title":"Myeloproliferative neoplasms","volume":"Vol 2","author":"Thiele","year":"2008"},{"key":"10.1016\/j.clml.2019.05.005_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.05.005_bib9","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","article-title":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs","volume":"30","author":"Emanuel","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.05.005_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0034-1370794","article-title":"Thrombosis in myeloproliferative neoplasms","volume":"40","author":"Falanga","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.clml.2019.05.005_bib11","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.V128.22.1951.1951","article-title":"Incidence of early thrombosis in myeloproliferative neoplasms (MPN): a prospective analysis from the Gruppo Laziale of Ph-Negative MPN","volume":"128","author":"Di Veroli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.05.005_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41408-017-0035-6","article-title":"Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients","volume":"7","author":"Cerquozzi","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2019.05.005_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00277-016-2853-1","article-title":"JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort","volume":"96","author":"Ianotto","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.05.005_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.thromres.2014.11.006","article-title":"The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms","volume":"135","author":"Borowczyk","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2019.05.005_bib15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.thromres.2015.07.008","article-title":"The JAK2 V617F mutational status and allele burden","volume":"136","author":"Liang","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2019.05.005_bib16","first-page":"340","article-title":"Management of symptoms in polycythemia vera and\u00a0essential\u00a0thrombocythemia patients","volume":"2015","author":"Radia","year":"2015","journal-title":"ASH Education Book"},{"key":"10.1016\/j.clml.2019.05.005_bib17","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.clml.2020.01.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000}}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501930254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501930254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:32:15Z","timestamp":1761870735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226501930254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S215226501930254X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.05.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Silent Thrombosis in Patients Younger Than 60 Years With Myeloproliferative Neoplasms: Single-Center Egyptian Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}